Beta Bionics Inc.’s concept of an artificial pancreas that regulates blood sugar levels in people with type 1 diabetes (T1D) ...

Nearly 70% of people with diabetes believe there is stigma associated with their condition, according to a survey from Abbott ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

"Grey's Anatomy" star Debbie Allen lost her father and aunt to diabetes. Now, she advocating for more representation.

CGMs are transforming health tracking for non-diabetics, providing insights into glucose levels and influencing dietary choices and athletic performance.

People who have diabetes will receive an opportunity to learn more about monitors, pumps and other devices during Columbus Community Hospital’s Spring Diabetes Technology Fair. The event will take ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Abbott is officially bringing the noise—literally—by launching a clinical trial for its new intravascular lithotripsy (IVL) ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

The US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s ...

ATTD conference, experts debated whether patients who use continuous glucose monitoring should aim for normal glycemia.

Users of Abbott’s CGM device can now view data and gain additional insights through Glooko’s diabetes management platform.